Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.83)
# 431
Out of 4,504 analysts
385
Total ratings
53.4%
Success rate
23.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $151 | $108.40 | +39.30% | 30 | Jul 7, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | $436 | $485.39 | -10.18% | 38 | Jul 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $429 | $298.76 | +43.59% | 35 | Jun 29, 2026 | |
| NGNE Neurogene | Maintained: Buy | $180 | $39.63 | +354.20% | 5 | Jun 29, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $227 | $144.76 | +56.81% | 20 | Jun 25, 2026 | |
| PHAR Pharming Group | Maintained: Buy | $37 | $13.86 | +166.96% | 3 | Jun 22, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Buy | $49 | $14.22 | +244.71% | 22 | Jun 16, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $79 | $33.82 | +133.59% | 23 | Jun 10, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $8 | $0.7927 | +909.21% | 16 | Jun 5, 2026 | |
| BBIO BridgeBio Pharma | Initiated Coverage: Buy | $104 | $85.89 | +21.09% | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $1.47 | +648.30% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $116 → $111 | $59.12 | +87.75% | 20 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $32.68 | +129.50% | 5 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $6.25 | +588.00% | 15 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.8704 | +474.45% | 24 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $6.97 | +201.29% | 28 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.91 | +155.75% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $6.34 | +168.14% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.57 | +403.28% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $114 | $365.81 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $18.95 | n/a | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $129.83 | n/a | 4 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $116.71 | n/a | 1 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $42.63 | n/a | 4 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $27 | $122.13 | n/a | 2 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 | $0.10 | n/a | 5 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.26 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $53.35 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $34.37 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $16 | $10.34 | n/a | 5 | May 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.05 | n/a | 2 | Jan 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.09 | n/a | 1 | May 13, 2014 |
Rhythm Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $151
Current: $108.40
Upside: +39.30%
Vertex Pharmaceuticals
Jul 6, 2026
Maintained: Hold
Price Target: $436
Current: $485.39
Upside: -10.18%
Alnylam Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $429
Current: $298.76
Upside: +43.59%
Neurogene
Jun 29, 2026
Maintained: Buy
Price Target: $180
Current: $39.63
Upside: +354.20%
Palvella Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $227
Current: $144.76
Upside: +56.81%
Pharming Group
Jun 22, 2026
Maintained: Buy
Price Target: $37
Current: $13.86
Upside: +166.96%
Intellia Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $49
Current: $14.22
Upside: +244.71%
Ultragenyx Pharmaceutical
Jun 10, 2026
Maintained: Buy
Price Target: $79
Current: $33.82
Upside: +133.59%
Fractyl Health
Jun 5, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7927
Upside: +909.21%
BridgeBio Pharma
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $85.89
Upside: +21.09%
May 27, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $1.47
Upside: +648.30%
May 22, 2026
Maintained: Buy
Price Target: $116 → $111
Current: $59.12
Upside: +87.75%
May 21, 2026
Maintained: Buy
Price Target: $75
Current: $32.68
Upside: +129.50%
May 19, 2026
Maintained: Buy
Price Target: $43
Current: $6.25
Upside: +588.00%
May 18, 2026
Maintained: Buy
Price Target: $5
Current: $0.8704
Upside: +474.45%
May 8, 2026
Maintained: Buy
Price Target: $21
Current: $6.97
Upside: +201.29%
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
May 6, 2026
Maintained: Buy
Price Target: $17
Current: $6.34
Upside: +168.14%
Apr 21, 2026
Maintained: Buy
Price Target: $23
Current: $4.57
Upside: +403.28%
Feb 28, 2022
Maintained: Buy
Price Target: $83 → $114
Current: $365.81
Upside: n/a
Sep 15, 2021
Upgraded: Buy
Price Target: n/a
Current: $18.95
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $129.83
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $116.71
Upside: n/a
Jun 25, 2020
Maintained: Hold
Price Target: n/a
Current: $42.63
Upside: n/a
Dec 16, 2019
Maintained: Buy
Price Target: $18 → $27
Current: $122.13
Upside: n/a
Nov 9, 2018
Downgraded: Hold
Price Target: $18
Current: $0.10
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $3.26
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $53.35
Upside: n/a
Oct 9, 2018
Initiated Coverage: Buy
Price Target: $35
Current: $34.37
Upside: n/a
May 4, 2017
Reiterated: Buy
Price Target: $19 → $16
Current: $10.34
Upside: n/a
Jan 11, 2017
Maintained: Hold
Price Target: n/a
Current: $2.05
Upside: n/a
May 13, 2014
Maintained: Hold
Price Target: n/a
Current: $4.09
Upside: n/a